Cargando…

Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue

Aldoketoreductase 1C3 (AKR1C3) is a functional prostaglandin F synthase and a negative modulator of the availability of ligands for the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARγ). AKR1C3 expression is known to be associated with adiposity, one of the components of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svensson, Per-arne, Gabrielsson, Britt G., Jernås, Margareta, Gummesson, Anders, Sjöholm, Kajsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SP Versita 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275867/ https://www.ncbi.nlm.nih.gov/pubmed/18641923 http://dx.doi.org/10.2478/s11658-008-0025-6

Ejemplares similares

AKR1C2 and AKR1C3 expression in adipose tissue: Association with body fat distribution and regulatory variants
por: Ostinelli, Giada, et al.
Publicado: (2021)

No Evidence for a Role of Adipose Tissue-Derived Serum Amyloid A in the Development of Insulin Resistance or Obesity-Related Inflammation in hSAA1(+/−) Transgenic Mice
por: Ahlin, Sofie, et al.
Publicado: (2013)

Roles of AKR1C3 in malignancy
por: Xiao, Xin-Zhu, et al.
Publicado: (2021)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

Human adipose tissue gene expression of solute carrier family 19 member 3 (SLC19A3); relation to obesity and weight‐loss
por: Pereira, Maria J., et al.
Publicado: (2021)

Adipose Tissue-Derived Human Serum Amyloid A Does Not Affect Atherosclerotic Lesion Area in hSAA1(+/−/)ApoE(−/−) Mice
por: Ahlin, Sofie, et al.
Publicado: (2014)

ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease
por: Carlsson, Lena M.S., et al.
Publicado: (2009)

AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

Establishment of a Transgenic Mouse Model Specifically Expressing Human Serum Amyloid A in Adipose Tissue
por: Olsson, Maja, et al.
Publicado: (2011)

ODP001 AKR1C2 Activity in Abdominal Adipose Tissue of Women with or without Excess Visceral Adiposity
por: Ostinelli, Giada, et al.
Publicado: (2022)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
por: Khanim, F, et al.
Publicado: (2014)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2017)

The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death
por: Li, Wei, et al.
Publicado: (2016)

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
por: Möller, Gabriele, et al.
Publicado: (2022)

MON-203 Local Activation of 11-Oxygenated Androgens by AKR1C3 Is the Predominant Source of Androgens in Human Female Adipose Tissue
por: Schiffer, Lina, et al.
Publicado: (2019)

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
por: Karason, Kristjan, et al.
Publicado: (2006)

Regulation of the Fibrosis and Angiogenesis Promoter SPARC/Osteonectin in Human Adipose Tissue by Weight Change, Leptin, Insulin, and Glucose
por: Kos, Katrina, et al.
Publicado: (2009)

Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
por: Zeng, Chen-Ming, et al.
Publicado: (2017)

AKR1C3 Overexpression Mediates Methotrexate Resistance in Choriocarcinoma Cells
por: Zhao, Jing, et al.
Publicado: (2014)

AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2020)

Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death
por: Phoo, Nang Lae Lae, et al.
Publicado: (2021)

Regulation of carboxylesterase 1 (CES1) in human adipose tissue
por: Jernås, Margareta, et al.
Publicado: (2009)

Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses
por: Arthur, Jonathan W., et al.
Publicado: (2010)

Adipose Tissue Resting Energy Expenditure and Expression of Genes Involved in Mitochondrial Function Are Higher in Women than in Men
por: Nookaew, Intawat, et al.
Publicado: (2013)

Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
por: Tavares, Tássia S., et al.
Publicado: (2020)

Lymphoma susceptibility of the thetaC3H AKR/CUM.
por: Tuffrey, M. A., et al.
Publicado: (1977)

Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
por: Schulze, Jenny J., et al.
Publicado: (2012)

Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer
por: Nakarai, Chiaki, et al.
Publicado: (2014)

AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
por: ZHU, Hong, et al.
Publicado: (2018)

AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
por: Tian, Yuantong, et al.
Publicado: (2014)

Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation
por: Sun, Shao-Qian, et al.
Publicado: (2016)

AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker
por: Reddi, Deepti, et al.
Publicado: (2022)

Inhibition of castration-resistant prostate cancer growth by genistein through suppression of AKR1C3
por: Yu, Xiaoping, et al.
Publicado: (2023)

AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)

Aldo-keto Reductase 1C3 (AKR1C3) is Expressed in Differentiated Human Epidermis, Affects Keratinocyte Differentiation and is Upregulated in Atopic Dermatitis
por: Mantel, Alon, et al.
Publicado: (2011)

AKR1C enzymes sustain therapy resistance in paediatric T-ALL
por: Bortolozzi, Roberta, et al.
Publicado: (2018)

Decreased Expression of Type 5 17β-Hydroxysteroid Dehydrogenase (AKR1C3) Protein Identified in Human Diabetic Skin Tissue
por: Cho, Moon-Kyun
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hj29crics2pdsa0r04s0aqd6o4